Information about SaveRxCanada.to
List of countries where we can ship Vidagliptin:
Latest news releases on Vidagliptin:
Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) ...
3 4.2 Posology and method of administration Posology Adults When used as monotherapy, in combination with metformin, in combination with thiazolidinedione,
Vildagliptin is a medicine available in a number of countries worldwide. A list of US medications equivalent to Vildagliptin is available on the Drugs.com website.
Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose. An extensive clinical program involving approximately ...
Vildagliptin, previously identified as LAF237, is a new oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class ...
Vildagliptin is an antidiabetic injection that is used to treat diabetes. For more information about diabetes treatments and vildagliptin visit Patient
Galvus 50 mg Tablets - by Novartis Pharmaceuticals UK Ltd
European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.
本網頁資料僅供參考，如有疑問或錯誤請仍依廠商資料為主。 醫令碼: 23710: 健保碼: bc25306100: 商品名: galvus ★ 50mg: 藥品許可證
Vildagliptin (Galvus) is a new class of drugs for the treatment of Type 2 diabetes. This drug reduces blood glucose by enhancing the effects of incretins - hormones ...